Press Releases
Home › Press Releases
The news index is intended for investors and media professionals who are looking to learn more about Angiotech. We hope you find this information useful and if you can't find what you are looking for, please feel free to contact us.
All press releases and other information listed below were, to the best of Angiotech's knowledge, timely and accurate when issued. However, the passage of time can render information stale, and you should not rely on the continued accuracy of any such material beyond the date of issuance. Angiotech does not assume the obligation to update this information. All viewers should carefully check the dates of issuance of the material contained in the Angiotech site.
2008
- November 21Angiotech Announces Termination of Note Purchase Agreement with Ares Management and New Leaf Venture Partners
- November 6Angiotech Announces Results for the Third Quarter Ended September 30, 2008
- October 28Notice of Conference Call and Webcast: Third Quarter 2008 Financial Results and Confirmation of Annual and Special General Meeting of Shareholders
- October 24Angiotech Annouces Webcast and Call-in Numbers for Annual and Special General Meeting of Shareholders
- October 10Angiotech's Corporate Partner, Boston Scientific, Announces FDA Approval of Second-Generation TAXUS® Liberté® Drug-Eluting Stent
- October 8Angiotech's Corporate Partner, Boston Scientific, Announces Completion of Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent
- September 25Angiotech Announces Date of Annual and Special General Meeting of Shareholders
- September 25Angiotech's Corporate Partner, Boston Scientific, Announces FDA Approval of TAXUS® Express2™ Atom™ Stent System, First Drug-Eluting Stent for Small Vessels
- September 23Angiotech Announces the Termination of its Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
- September 22Angiotech Announces Reorganization and Cost Reduction Initiatives, Updates Financial Outlook
- September 12Angiotech Announces Extension of the Expiration Date of its Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
- September 10Angiotech's Corporate Partner, Cook Medical, Completes Enrollment in First International Trial of Drug-eluting Peripheral Stent and Files for CE Mark in Europe
- August 22Angiotech Announces Extension of the Expiration Date of its Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
- August 12Angiotech Receives CE Mark Approval of HemoStream™ Chronic Dialysis Catheter
- July 28Angiotech Announces Results for the Second Quarter Ended June 30, 2008
- July 15Notice of Conference Call and Webcast: Second Quarter 2008 Financial Results
- July 10Angiotech Wins Before the UK House of Lords
- July 7Angiotech to Establish Separate Operating and Royalty Businesses
- July 7Angiotech to Commence Cash Tender for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes due 2014
- June 13Angiotech Announces Market Launch of Quill™ SRS MONODERM™
- June 11Angiotech's Corporate Partner, Cook Medical, Announces Positive Interim Results for its Zilver® PTX™ Clinical Study
- June 3Angiotech Announces Completion of Bio-Seal™ Clinical Trial Enrolment
- May 13Angiotech Appoints Hank McKinnell to its Board of Directors
- May 8Angiotech to Participate in Bank of America Health Care Conference
- May 1Angiotech Expands Quill™ SRS Product Offering Receiving FDA 510(k) Approval for Smaller Size Diameters of Quill™ SRS PDO
- April 29Angiotech Announces Results for the First Quarter Ended March 31, 2008
- April 21Angiotech Elects to Suspend Vascular Wrap™ Pivotal Clinical Trials
- April 18Angiotech's Corporate Partner, Boston Scientific, Reports Canadian Approval for Taxus® Liberté® Stent System
- April 17Angiotech's Novel 5-FU Central Venous Catheter Receives FDA 510(k) Clearance
- April 15Angiotech Announces Director Resignation
- April 15Notice of Conference Call and Webcast: First Quarter 2008 Financial Results
- April 4Angiotech Announces Commercial Launch of Cook Medical's Zilver® PTX™ Drug-eluting Peripheral Stent in New Zealand
- March 20Angiotech to Participate in Credit Suisse Global Leveraged Finance Conference
- March 18960-Patient Study Demonstrates Zero Blood Stream Infection in Patients Treated with Angiotech's Novel 5-FU Central Venous Catheter
- March 17Angiotech to Participate in Lehman Brothers Healthcare Conference
- March 13Angiotech Announces Filing of Audited Financial Results for the Year Ended December 31, 2007 and Restatement of Results for the Year Ended December 31, 2006
- March 13Angiotech and Rex Medical Announce Exclusive Licensing and Distribution Agreement for the "Option™" Inferior Vena Cava Filter
- March 13Angiotech Showcases its HemoStream™ Dialysis Catheter at the Society of Interventional Radiology (SIR) Annual Meeting; An Innovative Chronic Dialysis Catheter With Patented Triple Arterial Lumen Design
- February 14Angiotech Announces Results for the Fourth Quarter Ended December 31, 2007
- January 29Angiotech to Participate in Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
- January 22Notice of Conference Call and Webcast: Fourth Quarter 2007 Financial Results
- January 17Angiotech and Symphony Medical Announce Licensing Agreement